Cargando…

Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y(12) inhibitors

Platelets play pivotal roles in hemostasis as well as pathological arterial thrombosis. The combination of aspirin and a P2Y(12) inhibitor has become the mainstay therapy in the ageing population with cardiovascular conditions, particularly during and after percutaneous coronary intervention. A numb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzeffi, Michael A., Lee, Khang, Taylor, Bradley, Tanaka, Kenichi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Anesthesiologists 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548939/ https://www.ncbi.nlm.nih.gov/pubmed/28794832 http://dx.doi.org/10.4097/kjae.2017.70.4.379

Ejemplares similares

Optimal use of antiplatelet agents, especially aspirin, in the perioperative management of colorectal cancer patients undergoing laparoscopic colorectal resection
por: Yoshimoto, Yasunori, et al.
Publicado: (2019)

Role of prothrombin complex concentrate in perioperative coagulation therapy
por: Tanaka, Kenichi A, et al.
Publicado: (2014)

P2Y12 Inhibitors Exacerbate Low-dose Aspirin-induced Small Bowel Injury in Dual Antiplatelet Therapy
por: Handa, Yukiko, et al.
Publicado: (2021)

Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?
por: Borges, Juliana Maria Dantas Mendonça, et al.
Publicado: (2018)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

New anticoagulants and antiplatelet agents in perioperative period: Recommendations and controversies!
por: Nair, Abhijit S, et al.
Publicado: (2017)

Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016)

Antiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrel
por: KIRKBY, N S, et al.
Publicado: (2011)

Sex-Related Bleeding Risk in Acute Coronary Syndrome Patients Receiving Dual Antiplatelet Therapy with Aspirin and a P2Y12 Inhibitor
por: ten Haaf, Monique E., et al.
Publicado: (2023)

Cilostazol combined with P2Y(12) receptor inhibitors: A substitute antiplatelet regimen for aspirin‐intolerant patients undergoing percutaneous coronary stent implantation
por: Zhao, Yikai, et al.
Publicado: (2022)

Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor
por: Marczewski, Margaret M, et al.
Publicado: (2010)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Aspirin and P2Y12 inhibitors in treating COVID-19
por: Khalaji, Amirmohammad, et al.
Publicado: (2023)

The Auscultation of a Carbon Dioxide Embolization Event during Endoscopic Vein Harvest
por: Strauss, Erik, et al.
Publicado: (2016)

Factors Associated with Inadequate Management of Antiplatelet Agents in Perioperative Period of Non-Cardiac Surgeries
por: Borges, Juliana Maria Dantas Mendonça, et al.
Publicado: (2018)

Personalized antiplatelet therapy with P2Y(12) receptor inhibitors: benefits and pitfalls
por: Winter, Max-Paul, et al.
Publicado: (2015)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents
por: Testa, L., et al.
Publicado: (2010)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Aspirin Monotherapy beyond 12 Months of Dual Antiplatelet Therapy in Patients with Acute Myocardial Infarction: Oldies But Goodies?
por: Suh, Jung-Won
Publicado: (2019)

Perioperative Management of Antiplatelet-Drugs in Cardiac Surgery
por: Ferrandis, Raquel, et al.
Publicado: (2009)

Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010)

Comparative Evaluation of Direct Thrombin and Factor Xa Inhibitors with Antiplatelet Agents under Flow and Static Conditions: An In Vitro Flow Chamber Model
por: Hosokawa, Kazuya, et al.
Publicado: (2014)

Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y(12) Inhibitor Thereafter
por: Lahu, Shqipdona, et al.
Publicado: (2022)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
por: Lösche, Wolfgang, et al.
Publicado: (2012)

Risk factors for the effect of anticoagulant and antiplatelet agents on perioperative blood loss following proximal femoral fractures
por: Akaoka, Yusuke, et al.
Publicado: (2016)

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Genetic testing in antiplatelet therapy – not effective for perioperative bleeding
por: Kuliczkowski, Wiktor
Publicado: (2017)

Focus on the agents most frequently responsible for perioperative anaphylaxis
por: Di Leo, E., et al.
Publicado: (2018)

Dual Antiplatelet Therapy with Parenteral P2Y(12) Inhibitors: Rationale, Evidence, and Future Directions
por: Alagna, Giulia, et al.
Publicado: (2023)

Perioperative management of patient on aspirin: Current view
por: Bansal, Teena
Publicado: (2017)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Continuation versus discontinuation of aspirin-based antiplatelet therapy for perioperative bleeding and ischaemic events in adults undergoing neurosurgery: protocol for a systematic review and meta-analysis
por: Wang, Xinyan, et al.
Publicado: (2021)

Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9e994b9gj1dk0l8bbj12d51qar